Cybin Inc. (HELP)
NASDAQ · Healthcare
$7.11-1.93%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $352.25M
- P/E ratio
- —
- EPS
- —
- Volume
- 1,292,958
- 52-week high
- —
- 52-week low
- —
- Open
- $7.20
- Day high
- $7.39
- Day low
- $7.08
Financial highlights
Annual financials for Cybin Inc. are being compiled and will appear here soon.
About Cybin Inc.
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
- CEO
- Eric So
- Employees
- 100
- Country
- CA
- IPO date
- Sep 13, 2019
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Cybin Inc.'s stock price today?
- HELP is trading at $7.11 as of Jul 20, 2026.
- What is Cybin Inc.'s market cap?
- Cybin Inc. (HELP) has a market capitalization of $352.25M.
- What sector is Cybin Inc. in?
- Cybin Inc. operates in the Healthcare sector.